최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기European journal of clinical nutrition, v.71 no.9, 2017년, pp.1033 - 1039
Mohammadi-Sartang, M (Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran) , Mazloom, Z (Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran) , Sherafatmanesh, S (Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran) , Ghorbani, M (Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran) , Firoozi, Donya (Department of Clinical Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences, Shiraz, Iran)
Promising experimental studies suggest that quercetin has potential anti-inflammatory effects. However, the results of current clinical trials on quercetin’s effects on the C-reactive protein (CRP), a sensitive inflammatory biomarker, are ambiguous. We conducted a meta-analysis of available ra...
BMJ P Knekt 312 478 1996 10.1136/bmj.312.7029.478 Knekt P, Jarvinen R, Reunanen A, Maatela J . Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 1996; 312: 478-481.
Front Plant Sci MLF Ferreyra 3 222 2012 Ferreyra MLF, Rius SP, Casati P . Flavonoids: biosynthesis, biological functions, and biotechnological applications. Front Plant Sci 2012; 3: 222.
Nutr Res I Erlund 24 851 2004 10.1016/j.nutres.2004.07.005 Erlund I . Review of the flavonoids quercetin, hesperetin, and naringenin. Dietary sources, bioactivities, bioavailability, and epidemiology. Nutr Res 2004; 24: 851-874.
Fitoterapia G D'Andrea 106 256 2015 10.1016/j.fitote.2015.09.018 D'Andrea G . Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia 2015; 106: 256-271.
Curr Top Med Chem J Guillermo Gormaz 15 1735 2015 10.2174/1568026615666150427124357 Guillermo Gormaz J, Quintremil S, Rodrigo R . Cardiovascular disease: a target for the pharmacological effects of quercetin. Curr Top Med Chem 2015; 15: 1735-1742.
Atherosclerosis R Kleemann 218 44 2011 10.1016/j.atherosclerosis.2011.04.023 Kleemann R, Verschuren L, Morrison M, Zadelaar S, van Erk MJ, Wielinga PY et al. Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models. Atherosclerosis 2011; 218: 44-52.
Internet J Med Update P Lakhanpal 2 22 2007 Lakhanpal P, Rai DK . Quercetin: a versatile flavonoid. Internet J Med Update 2007; 2: 22-37.
J Nutr M Sanchez 137 910 2007 10.1093/jn/137.4.910 Sanchez M, Lodi F, Vera R, Villar IC, Cogolludo A, Jimenez R et al. Quercetin and isorhamnetin prevent endothelial dysfunction, superoxide production, and overexpression of p47phox induced by angiotensin II in rat aorta. J Nutr 2007; 137: 910-915.
J Thromb Haemost G Hubbard 1 1079 2003 10.1046/j.1538-7836.2003.00212.x Hubbard G, Stevens J, Cicmil M, Sage T, Jordan P, Williams C et al. Quercetin inhibits collagenstimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway. J Thromb Haemost 2003; 1: 1079-1088.
Life Sci MM Alam 109 8 2014 10.1016/j.lfs.2014.06.005 Alam MM, Meerza D, Naseem I . Protective effect of quercetin on hyperglycemia, oxidative stress and DNA damage in alloxan induced type 2 diabetic mice. Life Sci 2014; 109: 8-14.
Food Chem SF Nabavi 179 305 2015 10.1016/j.foodchem.2015.02.006 Nabavi SF, Russo GL, Daglia M, Nabavi SM . Role of quercetin as an alternative for obesity treatment: you are what you eat!. Food Chem 2015; 179: 305-310.
Anti-Cancer Agents Med Chem K Men 14 826 2014 10.2174/1871520614666140521122932 Men K, Duan X, Wei X, Ling Gou M, Juan Huang M, Juan Chen L et al. Nanoparticle-delivered quercetin for cancer therapy. Anti-Cancer Agents Med Chem 2014; 14: 826-832.
Curr Opin Clin Nutr Metab Care SC Bischoff 11 733 2008 10.1097/MCO.0b013e32831394b8 Bischoff SC . Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care 2008; 11: 733-740.
N Engl J Med Collaboration ERF 2012 1310 2012 10.1056/NEJMoa1107477 Collaboration ERF. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012; 2012: 1310-1320.
Curr Opin Nephrol Hypertens SK Venugopal 14 33 2005 10.1097/00041552-200501000-00006 Venugopal SK, Devaraj S, Jialal I . Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Curr Opin Nephrol Hypertens 2005; 14: 33-37.
Circulation V Pasceri 102 2165 2000 10.1161/01.CIR.102.18.2165 Pasceri V, Willerson JT, Yeh ET . Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
Food Funct N Das 4 889 2013 10.1039/c3fo30241e Das N, Sikder K, Bhattacharjee S, Majumdar SB, Ghosh S, Majumdar S et al. Quercetin alleviates inflammation after short-term treatment in high-fat-fed mice. Food Funct 2013; 4: 889-898.
J Gastroenterol R Gonzalez-Segovia 43 441 2008 10.1007/s00535-008-2184-7 Gonzalez-Segovia R, Quintanar JL, Salinas E, Ceballos-Salazar R, Aviles-Jimenez F, Torres-Lopez J . Effect of the flavonoid quercetin on inflammation and lipid peroxidation induced by Helicobacter pylori in gastric mucosa of guinea pig. J Gastroenterol 2008; 43: 441-447.
J Res Med Sci G Askari 17 637 2012 Askari G, Ghiasvand R, Feizi A, Ghanadian SM, Karimian J . The effect of quercetin supplementation on selected markers of inflammation and oxidative stress. J Res Med Sci 2012; 17: 637-641.
J Nutr S Egert 140 278 2010 10.3945/jn.109.117655 Egert S, Boesch-Saadatmandi C, Wolffram S, Rimbach G, Muller MJ . Serum lipid and blood pressure responses to quercetin vary in overweight patients by apolipoprotein E genotype. J Nutr 2010; 140: 278-284.
Br J Nutr S Egert 102 1065 2009 10.1017/S0007114509359127 Egert S, Bosy-Westphal A, Seiberl J, Kurbitz C, Settler U, Plachta-Danielzik S et al. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study. Br J Nutr 2009; 102: 1065-1074.
Int J Prev Med F Javadi 5 293 2014 Javadi F, Eghtesadi S, Ahmadzadeh A, Aryaeian N, Zabihiyeganeh M, Foroushani AR et al. The effect of quercetin on plasma oxidative status, C-reactive protein and blood pressure in women with rheumatoid arthritis. Int J Prev Med 2014; 5: 293-301.
Int J Prev Med M Zahedi 4 777 2013 Zahedi M, Ghiasvand R, Feizi A, Asgari G, Darvish L . Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial. Int J Prev Med 2013; 4: 777-785.
J Nutr JI Dower 145 1459 2015 10.3945/jn.115.211888 Dower JI, Geleijnse JM, Gijsbers L, Schalkwijk C, Kromhout D, Hollman PC . Supplementation of the pure flavonoids epicatechin and quercetin affects some biomarkers of endothelial dysfunction and inflammation in (pre) hypertensive adults: a randomized double-blind, placebo-controlled, crossover trial. J Nutr 2015; 145: 1459-1463.
Syst Rev D Moher 4 1 2015 10.1186/2046-4053-4-1 Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4: 1.
Controlled Clin Trials AR Jadad 17 1 1996 10.1016/0197-2456(95)00134-4 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clin Trials 1996; 17: 1-12.
Health Technol Assess D Moher 3 1 1999 10.3310/hta3120 Moher D, Cook D, Jadad A, Tugwell P, Moher M, Jones A et al. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses. Health Technol Assess 1999; 3: 1-98. i.
M Borenstein 104 2005 Comprehensive Meta-Analysis Version 2 Borenstein M, Hedges L, Higgins J, Rothstein H . Comprehensive Meta-Analysis Version 2. Biostat: Englewood, NJ, 2005, pp 104.
Br J Nutr V Brull 114 1263 2015 10.1017/S0007114515002950 Brull V, Burak C, Stoffel-Wagner B, Wolffram S, Nickenig G, Muller C et al. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial. Br J Nutr 2015; 114: 1263-1277.
Nutr Metab Cardiovasc Dis M Pfeuffer 23 403 2013 10.1016/j.numecd.2011.08.010 Pfeuffer M, Auinger A, Bley U, Kraus-Stojanowic I, Laue C, Winkler P et al. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different APOE isoforms. Nutr Metab Cardiovasc Dis 2013; 23: 403-409.
J Nutr JW Erdman 137 718S 2007 10.1093/jn/137.3.718S Erdman JW, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J et al. Flavonoids and heart health: proceedings of the ILSI North America flavonoids workshop, May 31-June 1, 2005, Washington, DC. J Nutr 2007; 137: 718S-737S.
Nutrition S Bhaskar 29 219 2013 10.1016/j.nut.2012.01.019 Bhaskar S, Kumar KS, Krishnan K, Antony H . Quercetin alleviates hypercholesterolemic diet induced inflammation during progression and regression of atherosclerosis in rabbits. Nutrition 2013; 29: 219-229.
Eur J Pharmacol V Garcia-Mediavilla 557 221 2007 10.1016/j.ejphar.2006.11.014 Garcia-Mediavilla V, Crespo I, Collado PS, Esteller A, Sanchez-Campos S, Tunon MJ et al. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur J Pharmacol 2007; 557: 221-229.
Int J Prev Med M Zahedi 4 777 2013 Zahedi M, Ghiasvand R, Feizi A, Asgari G, Darvishi L . Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: a double-blind randomized controlled clinical trial. Int J Prev Med 2013; 4: 777-785.
Nutrition AW Boots 24 703 2008 10.1016/j.nut.2008.03.023 Boots AW, Wilms LC, Swennen EL, Kleinjans JC, Bast A, Haenen GR . In vitro and ex vivo anti-inflammatory activity of quercetin in healthy volunteers. Nutrition 2008; 24: 703-710.
Obesity L Rivera 16 2081 2008 10.1038/oby.2008.315 Rivera L, Moron R, Sanchez M, Zarzuelo A, Galisteo M . Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity 2008; 16: 2081-2087.
Biochem Pharmacol WM Loke 75 1045 2008 10.1016/j.bcp.2007.11.002 Loke WM, Proudfoot JM, Stewart S, McKinley AJ, Needs PW, Kroon PA et al. Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: lack of association between antioxidant and lipoxygenase inhibitory activity. Biochem Pharmacol 2008; 75: 1045-1053.
Curr Pharm Des Y Kumazawa 12 4271 2006 10.2174/138161206778743565 Kumazawa Y, Kawaguchi K, Takimoto H . Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Curr Pharm Des 2006; 12: 4271-4279.
Food Chem Toxicol M Harwood 45 2179 2007 10.1016/j.fct.2007.05.015 Harwood M, Danielewska-Nikiel B, Borzelleca J, Flamm G, Williams G, Lines T . A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol 2007; 45: 2179-2205.
J Am Pharmaceut Assoc AM Ambrose 41 119 1952 10.1002/jps.3030410303 Ambrose AM, Robbins DJ, Deeds F . Comparative toxicities of quercetin and quercitrin. J Am Pharmaceut Assoc 1952; 41: 119-122.
Teratog Carcinog Mutagen D Saito 1 213 1980 10.1002/tcm.1770010209 Saito D, Shirai A, Matsushima T, Sugimura T, Hirono I . Test of carcinogenicity of quercetin, a widely distributed mutagen in food. Teratog Carcinog Mutagen 1980; 1: 213-221.
Cancer Lett I Hirono 13 15 1981 10.1016/0304-3835(81)90081-1 Hirono I, Ueno I, Hosaka S, Takanashi H, Matsushima T, Sugimura T et al. Carcinogenicity examination of quercetin and rutin in ACI rats. Cancer Lett 1981; 13: 15-21.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.